Entrepreneurial Innovation Bootcamp on Orphan Diseases

Please visit http://www.itn-profile.eu/bootcamp-entrepreneurial-innovation-orphan-diseases/(si apre in una nuova finestra) for all up to date information.

Target audience: life science researchers, clinicians, pharmaceutical industry and policy makers dealing with orphan diseases

The following topics will be covered during this bootcamp:

1) Key drivers and resistors in the orphan disease drugs and diagnostics landscape
2) Building a value proposition and sustainable business plan within the orphan disease ecosystem
3) Challenges in developing solutions for orphan diseases when moving outside R&D
4) Clinical trial design and strategic partnerships are key to ensure success
5) Ensuring access and affordability of orphan disease drugs

Speakers include:
Francis Arickx | RIZIV Belgium
Kristof Bonnarens | Pharma-be
Hans Büller | Fair Medicine
Paul Coppo | AP-HP Paris
Ann D’Hoore | AMGEN
Hilde De Winter | Ablynx
Carla Hollak | AMC Amsterdam
Vinciane Knappenberg | RIZIV Belgium
Diane Kleinermans | Belgian Ministry of Social Affairs and Health
Luc Kupers | Sanofi
Kristina Larsson | EMA
Ingrid Maes | Inovigate
Ana Palma | Sobi
Hanspeter Rottensteiner | Shire
Huub Schellekens | Universiteit Utrecht
Walter Van Dyck | Vlerick Business School
Agnès Veyradier | AP-HP Paris

and patient testimonials.

Venue: Provinciehuis Vlaams-Brabant, Leuven, Belgium

RIZIV and CME accreditation requested

Early bird registration until 30 June 2017.